DIMED (PNVL3) Main Indicators
Basic Data - PNVL3
| Company | DIMED |
| Corporate Name | DIMED S.A. DISTRIBUIDORA DE MEDICAMENTOS |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Comercio atacadista e varejista de medicamentos e produtos de perfumaria e toucador |
| Share | PNVL3 |
| Quote Date | 09/18/2024 |
| Share Type | ON |
| Last Closing | R$ 10.38 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 3.95 M |
| Last Statement | ITR - 06/30/2024 |
| Sector | Saúde |
| Subsector | Comércio e Distribuição |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | IBRA, ICON, IGC, IGCT, IGNM, ITAG, SMLL |
| Updated 09/19/2024 | |
Relative Prices - PNVL3
| Price/Earnings | 17.09 |
| Price/SBV | 1.33 |
| Price/Net Sales | 0.33 |
| Price/CFO | 4.86 |
| Price/FCF | 7.10 |
| Price/Total Assets | 0.50 |
| Price/EBIT | 9.63 |
| Price/Working Capital | 2.25 |
| Price/NCAV | -1.22 |
| EV/EBIT | 16.42 |
| EV/EBITDA | 7.27 |
| EV/Net Sales | 0.56 |
| EV/CFO | 8.28 |
| EV/FCF | 12.10 |
| EV/Total Assets | 0.85 |
| Company Market Cap | R$ 1.56 B |
| Enterprise Value | R$ 2.66 B |
| Current Financial Statement Date | 06/30/2024 |
| Current Share Price | R$ 10.38 |
| Share Price Date | 09/18/2024 |
| Dividend Yield | 3.35% |
| Updated 09/19/2024 | |
Income Statement - PNVL3
| Net Revenue | R$ 4.71 B |
| Gross Result | R$ 1.48 B |
| EBIT | R$ 162.10 M |
| Depreciation and Amortization | - R$ 204.01 M |
| EBITDA | R$ 366.11 M |
| Net Profit | R$ 91.34 M |
| Net Profit/Share | R$ 0.61 |
| Updated 08/14/2024 | |
| Net Revenue | R$ 1.13 B |
| Gross Result | R$ 363.41 M |
| EBIT | R$ 23.01 M |
| Depreciation and Amortization | - R$ 51.74 M |
| EBITDA | R$ 74.75 M |
| Net Profit | R$ 5.13 M |
| Profit/Share | R$ 0.03 |
| Updated 08/14/2024 | |
Price and Volume Behavior - PNVL3
| Lowest Price 52 weeks | R$ 9.48 |
| Highest Price 52 weeks | R$ 13.18 |
| Variation 2024 | -19.96% |
| Variation 1 year | -12.52% |
| Variation 2 years(total) | -7.96% |
| Variation 2 years(yearly) | -4.05% |
| Variation 3 years(total) | -32.82% |
| Variation 3 years(yearly) | -12.40% |
| Variation 4 years(total) | -53.73% |
| Variation 4 years(yearly) | -17.51% |
| Variation 5 years(total) | -25.12% |
| Variation 5 years(yearly) | -5.61% |
| Average Daily Volume (3 months) | R$ 3.46 M |
| Updated 09/19/2024 | |
Returns and Margins - PNVL3
| Return on Initial Tangible Capital | 5.23% |
| Return on Initial Invested Capital | 5.06% |
| Pre-Tax Return on Initial Tangible Capital | 7.93% |
| Pre-Tax Return on Initial Invested Capital | 7.67% |
| Return on Initial Shareholder´s Equity | 8.11% |
| Return on Initial Asset | 3.28% |
| Gross Margin | 31.35% |
| Net Margin | 1.94% |
| EBIT Margin | 3.44% |
| EBITDA Margin | 7.77% |
| Initial Asset Turnover | 1.69 |
| Financial Leverage | 2.69 |
| Liabilities/Net Worth | 1.69 |
| Net Debt/EBITDA | 3.01 |
| Updated 08/14/2024 | |
Balance Sheet - PNVL3
| Cash and Cash Equivalents | R$ 16.70 M |
| Total Assets | R$ 3.15 B |
| Short-Term Debt | R$ 350.29 M |
| Long-Term Debt | R$ 766.59 M |
| Gross Debt | R$ 1.12 B |
| Net Debt | R$ 1.10 B |
| Shareholder´s Equity | R$ 1.17 B |
| Share Book Value | R$ 7.79 |
| Common Shares | 150,377,481 |
| Preferred Shares | 0 |
| Total | 150,377,481 |
| Common Shares in Treasury | 1,019,740 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 1,019,740 |
| Common Shares (Except Treasury) | 149,357,741 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 149,357,741 |
| Updated 08/14/2024 | |
Cash Flow - PNVL3
| Operating Cash Flow | R$ 321.29 M |
| Cash Flow from Investments | - R$ 172.72 M |
| Financing Cash Flow | - R$ 144.15 M |
| Increase (Reduction) in Cash and Equivalents | R$ 4.43 M |
| Updated 08/14/2024 | |
| Operating Cash Flow | R$ 100.69 M |
| Cash Flow from Investments | - R$ 34.80 M |
| Financing Cash Flow | - R$ 71.32 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 5.43 M |
| Updated 08/14/2024 | |
Experimental - PNVL3
| CAPEX 3 months | - R$ 20.69 M |
| Free Cash Flow 3 months | R$ 80.00 M |
| CAPEX 12 months | - R$ 101.30 M |
| Free Cash Flow 12 months | R$ 219.99 M |
| Updated 08/14/2024 | |